These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 389826)

  • 1. Elimination of bacteria during antibacterial chemotherapy--a neglected parameter of chemotherapy.
    Helm EB; Munk I; Shah PM; Stille W
    Infection; 1979; 7 Suppl 5():S492-4. PubMed ID: 389826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative trial of amoxycillin and co-trimoxazole in the treatment of urinary-tract infection.
    Grob PR; Beynon GP; Gibbs FJ; Manners BT
    Practitioner; 1977 Aug; 219(1310):258-63. PubMed ID: 331295
    [No Abstract]   [Full Text] [Related]  

  • 3. [Profile of antimicrobial resistance of agents causing urinary tract infections in children].
    Ghedira Besbes L; Messaoudi A; Ben Meriem C; Guediche MN
    Tunis Med; 2004 Mar; 82(3):299-305. PubMed ID: 15382465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial Susceptibilities of Escherichia coli from Community-Acquired Urinary Tract Infections in the Faroe Islands, Associations with Antibacterial Sales, and Comparison with Iceland and Denmark.
    Magnussen MD; Gislason H; Gaini S; Kristinsson KG
    Microb Drug Resist; 2018; 24(1):40-47. PubMed ID: 28537778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim in vitro antibacterial activity is not increased by adding sulfamethoxazole for pediatric Escherichia coli urinary tract infection.
    Nguyen HT; Hurwitz RS; Defoor WR; Minevich E; McAdam AJ; Mortensen JE; Novak-Weekley SM; Minnillo BJ; Elder JS
    J Urol; 2010 Jul; 184(1):305-10. PubMed ID: 20488468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-lactamase production by strains of Escherichia coli of intermediate susceptibility to beta-lactam antibiotics. A study of their clinical significance in urinary tract infection.
    Brauner A; Dornbusch K; Hallander HO
    Scand J Infect Dis Suppl; 1978; (13):67-72. PubMed ID: 356181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cefixime and co-trimoxazole in acute uncomplicated urinary tract infection. A double-blind general practice study.
    Levenstein J; Summerfield PJ; Fourie S; Brink G; Michaelides B; Murray E; Naidoo N
    S Afr Med J; 1986 Oct; 70(8):455-60. PubMed ID: 3535127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norfloxacin versus co-trimoxazole for treatment of urinary tract infections in adults: microbiological results of a coordinated multicentre study.
    Rylander M; Norrby SR; Svärd R
    Scand J Infect Dis; 1987; 19(5):551-7. PubMed ID: 3321412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ampicillin and trimethoprim-sulfamethoxazole in the short-term treatment of urinary tract infection.
    Laplante L; Beaudry C
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):7-9. PubMed ID: 1093655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Present status of the treatment of urological infections].
    Ukhin AV
    Antibiot Med Biotekhnol; 1985 May; 30(5):384-91. PubMed ID: 3896135
    [No Abstract]   [Full Text] [Related]  

  • 11. Trimethoprim-sulfamethoxazole vs ampicillin in chronic urinary tract infections. A double-blind multicenter cooperative controlled study.
    Gleckman RA
    JAMA; 1975 Aug; 233(5):427-31. PubMed ID: 1097747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Susceptibility of Escherichia coli strains isolated from persons with urinary tract infections in 2007 - 2008 to antimicrobial agents].
    Kot B; Wicha J; Zak-Puławska Z
    Przegl Epidemiol; 2010; 64(2):307-12. PubMed ID: 20731243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind trial to compare ampicillin, cephalexin, co-trimoxazole, and trimethoprim in treatment of urinary infection.
    Brumfitt W; Pursell R
    Br Med J; 1972 Jun; 2(5815):673-6. PubMed ID: 4555654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Bacterial Resistance Patterns of Pediatric Urinary Tract Infections and Rationale for Empirical Antibiotic Therapy.
    Gökçe İ; Çiçek N; Güven S; Altuntaş Ü; Bıyıklı N; Yıldız N; Alpay H
    Balkan Med J; 2017 Sep; 34(5):432-435. PubMed ID: 28443576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of ampicillin and trimethoprim/sulfamethoxazole on the periurethral flora of children with urinary tract infection.
    Sullivan TD; Ellerstein NS; Neter E
    Infection; 1980; 8 Suppl 3():S 339-41. PubMed ID: 6997212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotic sensitivity and immediate clinical response in urinary tract infections].
    Bugnon A; Sakellaridès E; Schelling JL; Bonifas V
    Schweiz Med Wochenschr; 1972 Oct; 102(40):1407-11. PubMed ID: 4567937
    [No Abstract]   [Full Text] [Related]  

  • 17. Trimethoprim--sulphamethoxazole: comparative study in urinary infection in hospital.
    Reeves DS; Faiers MC; Pursell RE; Brumfitt W
    Br Med J; 1969 Mar; 1(5643):541-4. PubMed ID: 4885025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing prevalence of antibiotic resistance and multi drug resistance among uropathogens.
    Anandkumar H; Kapur I; Dayanand A
    J Commun Dis; 2003 Jun; 35(2):102-8. PubMed ID: 15562956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trimethoprim-sulphamethoxazole (Bactrim) and ampicillin in urinary infections. A controlled follow-up investigation on a hospital material].
    Hansen AS; Faber-Hansen K; Holm P
    Ugeskr Laeger; 1973 Aug; 135(34):1817-20. PubMed ID: 4592620
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of a slow-release trimethoprim with co-trimoxazole: efficacy and selection of resistance in the Enterobacteriaceae.
    Menon R; Roberts FE; Barr KW; Howard H; Lord VL; Hegarty MA; Luxton DE; Lacey RW
    J Antimicrob Chemother; 1986 Sep; 18(3):415-20. PubMed ID: 3533889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.